Schedule 13G ownership disclosure

Audentes Therapeutics, Inc.

Security class unavailable · CUSIP: 05070R104

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,332,031
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-009321
Form type
SC 13G
Filer
5AM VENTURES III, L.P.
CIK
CIK 1456890
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub